RDHL.TA - RedHill Biopharma Ltd.

Tel Aviv - Tel Aviv Delayed Price. Currency in ILS
Currency in ILS
Earnings EstimateCurrent Qtr. (Sep 2016)Next Qtr. (Dec 2016)Current Year (2016)Next Year (2017)
No. of Analysts0001
Avg. Estimate000-0.25
Low Estimate000-0.25
High Estimate000-0.25
Year Ago EPSN/A-0.6N/AN/A
Revenue EstimateCurrent Qtr. (Sep 2016)Next Qtr. (Dec 2016)Current Year (2016)Next Year (2017)
No. of Analysts2211
Avg. EstimateN/AN/A101k7.5M
Low EstimateN/AN/AN/A7.5M
High Estimate340k800kN/A7.5M
Year Ago SalesN/AN/A3k101k
Sales Growth (year/est)N/AN/A3,266.70%7,325.70%
Earnings HistoryInvalid Date9/30/201412/31/20146/30/2016
EPS Est.N/A-0.61-0.6-0.06
EPS ActualN/A-0.6-0.6-0.06
DifferenceN/A0.0100
Surprise %N/A1.60%0.00%0.00%
EPS TrendCurrent Qtr. (Sep 2016)Next Qtr. (Dec 2016)Current Year (2016)Next Year (2017)
Current Estimate000-0.25
7 Days Ago-0.06-0.06-0.17-0.25
30 Days Ago-0.06-0.06-0.17-0.25
60 Days Ago-0.06-0.06-0.17-0.25
90 Days Ago-0.06-0.06-0.17-0.24
EPS RevisionsCurrent Qtr. (Sep 2016)Next Qtr. (Dec 2016)Current Year (2016)Next Year (2017)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesRDHL.TAIndustrySectorS&P 500
Current Qtr.N/AN/AN/A0.34
Next Qtr.N/AN/AN/A0.40
Current YearN/AN/AN/A0.17
Next YearN/AN/AN/A0.11
Next 5 Years (per annum)N/AN/AN/A0.12
Past 5 Years (per annum)N/AN/AN/AN/A